Challenges in Therapeutically Targeting the RNA ‐Recognition Motif
WIREs RNA · 2024
DOI: 10.1002/wrna.1877 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs RNA, 2024. Verfasst von Stefan Schmeing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Genomics Centre of the Max Planck Society, Max Planck Institute of Molecular Physiology, Dortmund, Germany. Hauptthemen laut MEDLINE: RNA Recognition Motif. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.
Abstract (Originalsprache)
The RNA recognition motif (RRM) is the most common RNA binding domain found in the human proteome. RRM domains provide RNA‐binding proteins with sequence specific RNA recognition allowing them to participate in RNA‐centric processes such as mRNA maturation, translation initiation, splicing, and RNA degradation. They are drivers of various diseases through overexpression or mutation, making them attractive therapeutic targets and addressing these proteins through their RRM domains with chemical compounds is gaining ever more attention. However, it is still very challenging to find selective and potent RNA‐competitors due to the small size of the domain and high structural conservation of its RNA binding interface. Despite these challenges, a selection of compounds has been reported for several RRM containing proteins, but often with limited biophysical evidence and low selectivity. A solution to selectively targeting RRM domains might be through avoiding the RNA‐binding surface altogether, but rather look for composite pockets formed with other proteins or for protein–protein interaction sites that regulate the target's activity but are less conserved. Alternative modalities, such as oligonucleotides, peptides, and molecular glues, are exciting new approaches to address these challenging targets and achieve the goal of therapeutic intervention at the RNA regulatory level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Genomics Centre of the Max Planck Society, Max Planck Institute of Molecular Physiology, Dortmund, Germany.
ORCID-Profile: Stefan Schmeing, Peter 't Hart
Förderung
- European Research Council
Zitieren
APA
Schmeing, S., & Hart, P. (2024). Challenges in Therapeutically Targeting the RNA ‐Recognition Motif. WIREs RNA. https://doi.org/10.1002/wrna.1877
Vancouver
Schmeing S, Hart P. Challenges in Therapeutically Targeting the RNA ‐Recognition Motif. WIREs RNA. 2024. doi:10.1002/wrna.1877
BibTeX
@article{Schmeing2024,
author = {Schmeing, Stefan and Hart, Peter 't},
title = {Challenges in Therapeutically Targeting the RNA ‐Recognition Motif},
journal = {WIREs RNA},
year = {2024},
doi = {10.1002/wrna.1877}
}
EUVIMED